tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market

Oncopeptides AB (ONCO) Income Statement

Compare
0 Followers

Oncopeptides AB Income Statement

Last quarter (Q3 2024), Oncopeptides AB's total revenue was kr8.51M, an increase of 203.28% from the same quarter last year. In Q3, Oncopeptides AB's net income was kr-60.23M. See Oncopeptides AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 35.22Mkr 8.36Mkr 118.30Mkr 0.00kr 0.00
Gross Profit
kr 36.30Mkr 8.35Mkr 65.17Mkr -14.40Mkr -4.54M
Operating Expenses
kr 289.75Mkr 357.70Mkr 1.49Bkr 1.59Bkr 739.39M
Depreciation and Amortization
kr 11.04Mkr 17.18Mkr 21.36Mkr 14.40Mkr 4.54M
EBITDA
kr -231.62Mkr -319.62Mkr -1.40Bkr -1.58Bkr -734.85M
Operating Income
kr -253.45Mkr -349.35Mkr -1.42Bkr -1.59Bkr -739.39M
Other Income/Expenses
kr 5.00Mkr 11.67Mkr -455.00Kkr -1.16Mkr -528.00K
Pretax Income
kr -248.45Mkr -337.68Mkr -1.42Bkr -1.59Bkr -739.92M
Net Income
kr -249.11Mkr -337.95Mkr -1.43Bkr -1.59Bkr -740.71M
Per Share Metrics
Basic EPS
kr -1.96kr -4.11kr -19.00kr -25.57kr -14.33
Diluted EPS
kr -1.96kr -4.11kr -19.00kr -25.57kr -14.33
Weighted Average Shares Outstanding
126.84M 82.32M 75.29M 62.37M 51.70M
Weighted Average Shares Outstanding (Diluted)
126.84M 82.32M 75.29M 62.37M 51.70M
Currency in SEK

Oncopeptides AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis